Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy

Kidney International

Volumn 82, Issue 9, 2012, Pages 1010-1017

  Weil, E Jennifer ^a   Lemley, Kevin V ^b   Mason, Clinton C ^a   Yee, Berne ^c   Jones, Lois I ^a   Blouch, Kristina ^d   Lovato, Tracy ^a   Richardson, Meghan ^a   Myers, Bryan D ^d   Nelson, Robert G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Southwest Kidney Institute   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

diabetic glomerulopathy; electron microscopy; endothelial cells; glomerular filtration rate; podocytes

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CAPILLARY ENDOTHELIUM; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; ENDOTHELIAL CELL FENESTRATION; FEMALE; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY FUNCTION TEST; MACROALBUMINURIA; MALE; MEMBRANE PERMEABILITY; MICROALBUMINURIA; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PODOCYTE; PODOCYTE DETACHMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84867576816     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.234     Document Type: Article

References (40)

1. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-2147
2. Satchell SC, Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 2009; 296: F947-F956
3. Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 2008; 74: 22-36
4. Steffes MW, Schmidt D, McCrery R. et al., International Diabetic Nephropathy Study Group. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001; 59: 2104-2113
5. White KE, Bilous RW. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 2004; 19: 1437-1440
6. Susztak K, Raff AC, Schiffer M. et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225-233
7. Miyauchi M, Toyoda M, Kobayashi K. et al. Hypertrophy and loss of podocytes in diabetic nephropathy. Intern Med 2009; 48: 1615-1620
8. Lindenmeyer MT, Kretzler M, Boucherot A. et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-1776
9. Toyoda M, Najafian B, Kim Y. et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007; 56: 2155-2160
10. Pagtalunan ME, Miller PL, Jumping-Eagle S. et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342-348
11. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 1999; 42: 1341-1344
12. Lemley KV, Abdullah I, Myers BD. et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney Int 2000; 58: 1228-1237
13. Dalla Vestra M, Masiero A, Roiter AM. et al. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 2003; 52: 1031-1035
14. Nakamura T, Ushiyama C, Suzuki S. et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000; 15: 1379-1383
15. Lemley KV, Blouch K, Abdullah I. et al. Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol 2000; 11: 2095-2105
16. Drumond MC, Deen WM. Structural determinants of glomerular capillary hydraulic permeability. Am J Physiol (Fluid, Renal, Electrolyte) 1994; 35: F1-F12
17. Singh A, Fridén V, Dasgupta I. et al. High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am J Physiol Renal Physiol 2011; 300: F40-F48
18. Nieuwdorp M, van Haeften TW, Gouverneur MC. et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55: 480-486
19. Lafayette RA, Druzin M, Sibley R. et al. Nature of glomerular dysfunction in pre-eclampsia. Kidney Int 1998; 54: 1240-1249
20. Mauer SM, Steffes MW, Ellis EN. et al. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984; 74: 1143-1155
21. Weil EJ, Lemley KV, Yee B. et al. Podocyte detachment in type 2 diabetic nephropathy. Am J Nephrol 2011; 33(Suppl 1): 21-24
22. Cohen AH, Mampaso F, Zamboni L. Glomerular podocyte degeneration in human renal disease: an ultrastructural study. Lab Invest 1977; 37: 30-42
23. Eremina V, Sood M, Haigh J. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707-716
24. Eremina V, Jefferson JA, Kowalewska J. et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358: 1129-1136
25. Baelde HJ, Eikmans M, Lappin DW. et al. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int 2007; 71: 637-645
26. Nelson RG, Meyer TW, Myers BD. et al. Course of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Kidney Int Suppl 1997; 63: S45-S48
27. Berhane AM, Weil EJ, Knowler WC. et al. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin J Am Soc Nephrol 2011; 6: 2444-2451
28. Perkins BA, Ficociello LH, Silva KH. et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003; 348: 2285-2293
29. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S. et al. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004; 27: 195-200
30. Schmidt K, Pesce C, Liu Q. et al. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol 1992; 3: 229-235
31. Nelson RG, Newman JM, Knowler WC. et al. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988; 31: 730-736
32. Tan JC, Busque S, Workeneh B. et al. Effects of aging on glomerular function and number in living kidney donors. Kidney Int 2010; 78: 686-692
33. Hoy WE, Samuel T, Hughson MD. et al. How many glomerular profiles must be measured to obtain reliable estimates of mean glomerular areas in human renal biopsies? J Am Soc Nephrol 2006; 17: 556-563
34. Jensen EB, Gundersen HJG, Osterby R. Determination of membrane thickness of distribution form orthogonal intercepts. J Microscopy 1979; 115: 19-33
35. Weibel ER. Practical Methods for Biological Morphometry. Academic Press: New York, 1979
36. Guasch A, Sibley RK, Huie P. et al. Extent and course of glomerular injury in human membranous glomerulopathy. Am J Physiol 1992; 264: F1034-F1043
37. Ting BD, Kristal B, Myers BD. The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy. Kidney Int 1994; 40: 390-397
38. Vasquez B, Flock EV, Savage PJ. et al. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia 1984; 26: 127-133
39. Chasson AL, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol 1960; 30: 207-212
40. Delanaye P, Radermecker RP, Rorive M. et al. Indexing glomerular filtration rate for body surface areas in obese patients is misleading: concepts and example. Nephrol Dial Transplant 2005; 20: 2024-2028.